logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
  • 1
    Fliri, Hans Georg, Dr
    Managing Director born in November 1944
    Individual (6 offsprings)
    Officer
    icon of calendar 2012-04-12 ~ now
    OF - Director → CIF 0
    Dr Hans Georg Fliri
    Born in November 1944
    Individual (6 offsprings)
    Person with significant control
    icon of calendar 2016-04-06 ~ now
    PE - Right to appoint or remove directorsCIF 0
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
  • 2
    Rummelt, Andreas, Dr
    Chief Executive born in June 1956
    Individual (2 offsprings)
    Officer
    icon of calendar 2013-07-01 ~ now
    OF - Director → CIF 0
Ceased 5
  • 1
    Kerr, Simon Christopher
    Ceo born in August 1957
    Individual (3 offsprings)
    Officer
    icon of calendar 2014-10-01 ~ 2019-03-19
    OF - Director → CIF 0
  • 2
    Baker-munton, Nicola Jane
    Ceo born in April 1964
    Individual (2 offsprings)
    Officer
    icon of calendar 2014-11-27 ~ 2023-05-12
    OF - Director → CIF 0
  • 3
    Hurley, Peter Laurence
    Chartered Accountant born in February 1944
    Individual
    Officer
    icon of calendar 2013-03-11 ~ 2017-12-05
    OF - Director → CIF 0
  • 4
    Williams, Kerry
    Individual (5 offsprings)
    Officer
    icon of calendar 2012-04-12 ~ 2017-12-31
    OF - Secretary → CIF 0
  • 5
    Saxby, Simon James Yvon
    Chief Executive born in February 1958
    Individual (1 offspring)
    Officer
    icon of calendar 2012-04-12 ~ 2013-02-28
    OF - Director → CIF 0
parent relation
Company in focus

CYPRALIS LIMITED

Previous name
SELCIA PHARMA LIMITED - 2013-10-17
Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Average Number of Employees
22024-01-01 ~ 2024-12-31
32023-01-01 ~ 2023-12-31
Intangible Assets
1,750 GBP2024-12-31
3,500 GBP2023-12-31
Debtors
Current
14,299 GBP2024-12-31
1,999 GBP2023-12-31
Cash at bank and in hand
1,361 GBP2024-12-31
402 GBP2023-12-31
Current Assets
15,660 GBP2024-12-31
2,401 GBP2023-12-31
Creditors
Current, Amounts falling due within one year
-1,133,646 GBP2023-12-31
Net Current Assets/Liabilities
-1,126,794 GBP2024-12-31
-1,131,245 GBP2023-12-31
Total Assets Less Current Liabilities
-1,125,044 GBP2024-12-31
-1,127,745 GBP2023-12-31
Net Assets/Liabilities
-1,125,044 GBP2024-12-31
-1,127,745 GBP2023-12-31
Equity
Called up share capital
206,735 GBP2024-12-31
206,735 GBP2023-12-31
Share premium
2,314,435 GBP2024-12-31
2,314,435 GBP2023-12-31
Retained earnings (accumulated losses)
-3,646,214 GBP2024-12-31
-3,648,915 GBP2023-12-31
Equity
-1,125,044 GBP2024-12-31
-1,127,745 GBP2023-12-31
Intangible Assets - Gross Cost
Development expenditure
1,750 GBP2024-12-31
3,500 GBP2023-12-31
Intangible Assets
Development expenditure
1,750 GBP2024-12-31
3,500 GBP2023-12-31
Other Debtors
Current
9,286 GBP2024-12-31
1,886 GBP2023-12-31
Prepayments/Accrued Income
Current
113 GBP2024-12-31
113 GBP2023-12-31
Amount of corporation tax that is recoverable
Current
4,900 GBP2024-12-31
Other Remaining Borrowings
Current
1,109,094 GBP2024-12-31
1,097,532 GBP2023-12-31
Trade Creditors/Trade Payables
Current
19,660 GBP2024-12-31
21,482 GBP2023-12-31
Accrued Liabilities/Deferred Income
Current
13,700 GBP2024-12-31
14,632 GBP2023-12-31
Creditors
Current
1,142,454 GBP2024-12-31
1,133,646 GBP2023-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
4,134,695 shares2024-12-31
4,134,695 shares2023-12-31
Par Value of Share
Class 1 ordinary share
0.052024-01-01 ~ 2024-12-31

Related profiles found in government register
  • CYPRALIS LIMITED
    Info
    SELCIA PHARMA LIMITED - 2013-10-17
    Registered number 08028515
    icon of addressSt Johns Innovation Centre, Cowley Road, Cambridge CB4 0WS
    Private Limited Company incorporated on 2012-04-12 (13 years 7 months). The company status is Active.
    The last date of confirmation statement was made at 2025-08-11
    CIF 0
  • CYPRALIS LIMITED
    S
    Registered number 08028515
    icon of addressSt Johns Innovation Centre, Cowley Road, Cambridge, England, CB4 0WS
    Limited in Cypralis Limited, United Kingdom
    CIF 1
child relation
Offspring entities and appointments
Active 1
  • icon of addressBridge End Orchard, 35 Bridge Street, Saffron Walden, England
    Dissolved Corporate (4 parents)
    Equity (Company account)
    0 GBP2021-12-31
    Person with significant control
    icon of calendar 2022-01-04 ~ dissolved
    CIF 1 - Ownership of voting rights - 75% or moreOE
    CIF 1 - Ownership of shares – 75% or moreOE

The content of this website is protected by AgonGuard.

© 2022-2025 Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 16 October 2025 and licensed under the Open Government Licence v3.0.